Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences

DALLAS, Texas–(BUSINESS WIRE)–Colossal Biosciences, the de-extinction company behind the woolly mammoth and thylacine, today announced the launch of Form Bio, a new independent company offering a breakthrough computational life sciences platform. Form Bio enters the market with an oversubscribed $30M Series A funding round led by JAZZ Venture Partners with participation from Thomas Tull, Colossal lead investor. Form Bio offers an advanced, comprehensive software platform that replaces cumbers

Leave a Reply

Your email address will not be published. Required fields are marked *